1 Cash-Producing Stock Worth Your Attention and 2 Facing Headwinds

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Cash flow is valuable, but it’s not everything - StockStory helps you identify the companies that truly put it to work. That said, here is one cash-producing company that leverages its financial strength to beat its competitors and two best left off your watchlist.

Two Stocks to Sell:

Lattice Semiconductor (LSCC)

Trailing 12-Month Free Cash Flow Margin: 26%

A global leader in its category, Lattice Semiconductor (NASDAQ:LSCC) is a semiconductor designer specializing in customer-programmable chips that enhance CPU performance for intensive tasks such as machine learning.

Why Do We Think Twice About LSCC?

1. Customers postponed purchases of its products and services this cycle as its revenue declined by 9% annually over the last two years
2. Efficiency has decreased over the last five years as its operating margin fell by 16.2 percentage points
3. 4.7 percentage point decline in its free cash flow margin over the last five years reflects the company’s increased investments to defend its market position

Lattice Semiconductor’s stock price of $146.29 implies a valuation ratio of 74.2x forward P/E. To fully understand why you should be careful with LSCC, check out our full research report (it’s free).

Chemed (CHE)

Trailing 12-Month Free Cash Flow Margin: 14.8%

With a unique business model combining end-of-life care and household services, Chemed (NYSE:CHE) operates two distinct businesses: VITAS, which provides hospice care for terminally ill patients, and Roto-Rooter, which offers plumbing and water restoration services.

Why Is CHE Not Exciting?

1. 4% annual revenue growth over the last five years was slower than its healthcare peers
2. Earnings growth over the last five years fell short of the peer group average as its EPS only increased by 2.8% annually
3. Shrinking returns on capital suggest that increasing competition is eating into the company’s profitability

Chemed is trading at $436.03 per share, or 17.4x forward P/E. Read our free research report to see why you should think twice about including CHE in your portfolio.

One Stock to Buy:

MercadoLibre (MELI)

Trailing 12-Month Free Cash Flow Margin: 37.2%

Originally started as an online auction platform, MercadoLibre (NASDAQ:MELI) is a one-stop e-commerce marketplace and fintech platform in Latin America.

Why Will MELI Outperform?

1. 77.7% annual increases in its average revenue per user over the last two years show its platform is resonating with power users
2. Share repurchases over the last three years enabled its annual earnings per share growth of 45.9% to outpace its revenue gains
3. Impressive free cash flow profitability enables the company to fund new investments or reward investors with share buybacks/dividends, and its growing cash flow gives it even more resources to deploy

At $1,651 per share, MercadoLibre trades at 18.8x forward EV/EBITDA. Is now the time to initiate a position? Find out in our full research report, it’s free.

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.